These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 25692347)

  • 1. Targeted next-generation sequencing in monogenic dyslipidemias.
    Hegele RA; Ban MR; Cao H; McIntyre AD; Robinson JF; Wang J
    Curr Opin Lipidol; 2015 Apr; 26(2):103-13. PubMed ID: 25692347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LipidSeq: a next-generation clinical resequencing panel for monogenic dyslipidemias.
    Johansen CT; Dubé JB; Loyzer MN; MacDonald A; Carter DE; McIntyre AD; Cao H; Wang J; Robinson JF; Hegele RA
    J Lipid Res; 2014 Apr; 55(4):765-72. PubMed ID: 24503134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single, short in-del, and copy number variations detection in monogenic dyslipidemia using a next-generation sequencing strategy.
    Marmontel O; Charrière S; Simonet T; Bonnet V; Dumont S; Mahl M; Jacobs C; Nony S; Chabane K; Bozon D; Janin A; Peretti N; Lachaux A; Bardel C; Millat G; Moulin P; Marçais C; Di Filippo M
    Clin Genet; 2018 Jul; 94(1):132-140. PubMed ID: 29572815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Next-generation sequencing using a pre-designed gene panel for the molecular diagnosis of congenital disorders in pediatric patients.
    Lim EC; Brett M; Lai AH; Lee SP; Tan ES; Jamuar SS; Ng IS; Tan EC
    Hum Genomics; 2015 Dec; 9():33. PubMed ID: 26666243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 2019 George Lyman Duff Memorial Lecture: Three Decades of Examining DNA in Patients With Dyslipidemia.
    Hegele RA; Dron JS
    Arterioscler Thromb Vasc Biol; 2020 Sep; 40(9):1970-1981. PubMed ID: 32762461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exome sequencing: new insights into lipoprotein disorders.
    Farhan SM; Hegele RA
    Curr Cardiol Rep; 2014 Jul; 16(7):507. PubMed ID: 24893940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a new expanded next-generation sequencing panel for genetic diseases involved in dyslipidemia.
    Marmontel O; Rollat-Farnier PA; Wozny AS; Charrière S; Vanhoye X; Simonet T; Chatron N; Collin-Chavagnac D; Nony S; Dumont S; Mahl M; Jacobs C; Janin A; Caussy C; Poinsot P; Tauveron I; Bardel C; Millat G; Peretti N; Moulin P; Marçais C; Di Filippo M
    Clin Genet; 2020 Dec; 98(6):589-594. PubMed ID: 33111339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exome sequencing in suspected monogenic dyslipidemias.
    Stitziel NO; Peloso GM; Abifadel M; Cefalu AB; Fouchier S; Motazacker MM; Tada H; Larach DB; Awan Z; Haller JF; Pullinger CR; Varret M; Rabès JP; Noto D; Tarugi P; Kawashiri MA; Nohara A; Yamagishi M; Risman M; Deo R; Ruel I; Shendure J; Nickerson DA; Wilson JG; Rich SS; Gupta N; Farlow DN; Neale BM; Daly MJ; Kane JP; Freeman MW; Genest J; Rader DJ; Mabuchi H; Kastelein JJ; Hovingh GK; Averna MR; Gabriel S; Boileau C; Kathiresan S
    Circ Cardiovasc Genet; 2015 Apr; 8(2):343-50. PubMed ID: 25632026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strategies for identifying the genetic basis of dyslipidemia: genome-wide association studies vs. the resequencing of extremes.
    Khor CC; Goh DL
    Curr Opin Lipidol; 2010 Apr; 21(2):123-7. PubMed ID: 20125008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Technological advances in DNA sequence enrichment and sequencing for germline genetic diagnosis.
    Ku CS; Wu M; Cooper DN; Naidoo N; Pawitan Y; Pang B; Iacopetta B; Soong R
    Expert Rev Mol Diagn; 2012 Mar; 12(2):159-73. PubMed ID: 22369376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progress in finding pathogenic DNA copy number variations in dyslipidemia.
    Iacocca MA; Dron JS; Hegele RA
    Curr Opin Lipidol; 2019 Apr; 30(2):63-70. PubMed ID: 30664016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance evaluation of the next-generation sequencing approach for molecular diagnosis of hereditary hearing loss.
    Sivakumaran TA; Husami A; Kissell D; Zhang W; Keddache M; Black AP; Tinkle BT; Greinwald JH; Zhang K
    Otolaryngol Head Neck Surg; 2013 Jun; 148(6):1007-16. PubMed ID: 23525850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Western Database of Lipid Variants (WDLV): a catalogue of genetic variants in monogenic dyslipidemias.
    Fu J; Kwok S; Sinai L; Abdel-Razek O; Babula J; Chen D; Farago E; Fernandopulle N; Leith S; Loyzer M; Lu C; Malkani N; Morris N; Schmidt M; Stringer R; Whitehead H; Ban MR; Dubé JB; McIntyre A; Johansen CT; Cao H; Wang J; Hegele RA
    Can J Cardiol; 2013 Aug; 29(8):934-9. PubMed ID: 23623477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Six years' experience with LipidSeq: clinical and research learnings from a hybrid, targeted sequencing panel for dyslipidemias.
    Dron JS; Wang J; McIntyre AD; Iacocca MA; Robinson JF; Ban MR; Cao H; Hegele RA
    BMC Med Genomics; 2020 Feb; 13(1):23. PubMed ID: 32041611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic testing in dyslipidemia: A scientific statement from the National Lipid Association.
    Brown EE; Sturm AC; Cuchel M; Braun LT; Duell PB; Underberg JA; Jacobson TA; Hegele RA
    J Clin Lipidol; 2020; 14(4):398-413. PubMed ID: 32507592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent developments in genome and exome-wide analyses of plasma lipids.
    Lange LA; Willer CJ; Rich SS
    Curr Opin Lipidol; 2015 Apr; 26(2):96-102. PubMed ID: 25692345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted next-generation sequencing: a novel diagnostic tool for primary immunodeficiencies.
    Nijman IJ; van Montfrans JM; Hoogstraat M; Boes ML; van de Corput L; Renner ED; van Zon P; van Lieshout S; Elferink MG; van der Burg M; Vermont CL; van der Zwaag B; Janson E; Cuppen E; Ploos van Amstel JK; van Gijn ME
    J Allergy Clin Immunol; 2014 Feb; 133(2):529-34. PubMed ID: 24139496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted next-generation sequencing panels for monogenetic disorders in clinical diagnostics: the opportunities and challenges.
    de Koning TJ; Jongbloed JD; Sikkema-Raddatz B; Sinke RJ
    Expert Rev Mol Diagn; 2015 Jan; 15(1):61-70. PubMed ID: 25367078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive next-generation cancer genome sequencing in the era of targeted therapy and personalized oncology.
    Cronin M; Ross JS
    Biomark Med; 2011 Jun; 5(3):293-305. PubMed ID: 21657839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical application of amplicon-based next-generation sequencing in cancer.
    Chang F; Li MM
    Cancer Genet; 2013 Dec; 206(12):413-9. PubMed ID: 24332266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.